Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 244

1.

Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.

Mas S, Gassó P, Torra M, Bioque M, Lobo A, González-Pinto A, Olmeda MS, Corripio I, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, Bobes J, Usall J, Llerena A, Saiz-Ruiz J, Bernardo M, Lafuente A, PEPs Group.

Eur Neuropsychopharmacol. 2017 Apr 4. pii: S0924-977X(17)30194-3. doi: 10.1016/j.euroneuro.2017.03.012. [Epub ahead of print]

PMID:
28389049
2.

Erratum to: Online information seeking by patients with bipolar disorder: results from an international multisite survey.

Conell J, Bauer R, Glenn T, Alda M, Ardau R, Baune BT, Berk M, Bersudsky Y, Bilderbeck A, Bocchetta A, Bossini L, Paredes Castro AM, Cheung EY, Chillotti C, Choppin S, Del Zompo M, Dias R, Dodd S, Duffy A, Etain B, Fagiolini A, Garnham J, Geddes J, Gildebro J, Gonzalez-Pinto A, Goodwin GM, Grof P, Harima H, Hassel S, Henry C, Hidalgo-Mazzei D, Kapur V, Kunigiri G, Lafer B, Lam C, Larsen ER, Lewitzka U, Licht RW, Lund AH, Misiak B, Piotrowski P, Monteith S, Munoz R, Nakanotani T, Nielsen RE, O'Donovan C, Okamura Y, Osher Y, Reif A, Ritter P, Rybakowski JK, Sagduyu K, Sawchuk B, Schwartz E, Scippa ÂM, Slaney C, Sulaiman AH, Suominen K, Suwalska A, Tam P, Tatebayashi Y, Tondo L, Vieta E, Vinberg M, Viswanath B, Volkert J, Zetin M, Zorrilla I, Whybrow PC, Bauer M.

Int J Bipolar Disord. 2017 Dec;5(1):18. doi: 10.1186/s40345-017-0082-8. Epub 2017 Mar 31. No abstract available.

3.

Gene-environment interaction as a predictor of early adjustment in first episode psychosis.

Fraguas D, Díaz-Caneja CM, Corripio I, González-Pinto A, Lobo A, Bioque M, Cuesta MJ, Sanjuán J, Rodríguez-Toscano E, Arias B, Sarró S, Cabrera B, Bulbena A, Vieta E, Castro-Fornieles J, Arango C, Bernardo M, Parellada M; PEPs group..

Schizophr Res. 2017 Mar 2. pii: S0920-9964(17)30110-X. doi: 10.1016/j.schres.2017.02.021. [Epub ahead of print]

PMID:
28262436
4.

Benzodiazepine prescriptions and falls in older men and women.

Martinez-Cengotitabengoa M, Diaz-Gutierrez MJ, Besga A, Bermúdez-Ampudia C, López P, Rondon MB, Stewart DE, Perez P, Gutierrez M, Gonzalez-Pinto A.

Rev Psiquiatr Salud Ment. 2017 Mar 2. pii: S1888-9891(17)30024-1. doi: 10.1016/j.rpsm.2017.01.004. [Epub ahead of print] English, Spanish.

5.

Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics.

Montejo ÁL, Arango C, Bernardo M, Carrasco JL, Crespo-Facorro B, Cruz JJ, Del Pino-Montes J, García-Escudero MA, García-Rizo C, González-Pinto A, Hernández AI, Martín-Carrasco M, Mayoral-Cleries F, Mayoral-van Son J, Mories MT, Pachiarotti I, Pérez J, Ros S, Vieta E.

Front Neuroendocrinol. 2017 Apr;45:25-34. doi: 10.1016/j.yfrne.2017.02.003. Epub 2017 Feb 21. Review.

PMID:
28235557
6.

The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.

Mezquida G, Cabrera B, Bioque M, Amoretti S, Lobo A, González-Pinto A, Espliego A, Corripio I, Vieta E, Castro-Fornieles J, Bergé D, Escartí MJ, Ibañez Á, Penadés R, Sánchez-Torres AM, Bernardo M; PEPs Group..

Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30060-9. doi: 10.1016/j.schres.2017.01.047. [Epub ahead of print]

PMID:
28185786
7.

Modelling gene-environment interaction in first episodes of psychosis.

Bernardo M, Bioque M, Cabrera B, Lobo A, González-Pinto A, Pina L, Corripio I, Sanjuán J, Mané A, Castro-Fornieles J, Vieta E, Arango C, Mezquida G, Gassó P, Parellada M, Saiz-Ruiz J, Cuesta MJ, Mas S; PEPs GROUP..

Schizophr Res. 2017 Feb 5. pii: S0920-9964(17)30068-3. doi: 10.1016/j.schres.2017.01.058. [Epub ahead of print]

PMID:
28179063
8.

Cannabis use, COMT, BDNF and age at first-episode psychosis.

Mané A, Bergé D, Penzol MJ, Parellada M, Bioque M, Lobo A, González-Pinto A, Corripio I, Cabrera B, Sánchez-Torres AM, Saiz-Ruiz J, Bernardo M, Group P.

Psychiatry Res. 2017 Apr;250:38-43. doi: 10.1016/j.psychres.2017.01.045. Epub 2017 Jan 19.

PMID:
28142064
9.

Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study.

Sanchez-Moreno J, Bonnín C, González-Pinto A, Amann BL, Solé B, Balanzá-Martínez V, Arango C, Jimenez E, Tabarés-Seisdedos R, Garcia-Portilla MP, Ibáñez A, Crespo JM, Ayuso-Mateos JL, Vieta E, Martinez-Aran A, Torrent C; CIBERSAM Functional Remediation Group..

Eur Neuropsychopharmacol. 2017 Apr;27(4):350-359. doi: 10.1016/j.euroneuro.2017.01.010. Epub 2017 Jan 23.

PMID:
28126401
10.

Psychoeducational preventive treatment for women at risk of postpartum depression: study protocol for a randomized controlled trial, PROGEA.

Ugarte AU, López-Peña P, Vangeneberg CS, Royo JG, Ugarte MA, Compains MT, Medrano MP, Toyos NM, Lamo EA, Dueñas MB, González-Pinto A.

BMC Psychiatry. 2017 Jan 13;17(1):13. doi: 10.1186/s12888-016-1162-5.

11.

Online psycho-education to the treatment of bipolar disorder: protocol of a randomized controlled trial.

González-Ortega I, Ugarte A, Ruiz de Azúa S, Núñez N, Zubia M, Ponce S, Casla P, Llano JX, Faria Á, González-Pinto A.

BMC Psychiatry. 2016 Dec 22;16(1):452. doi: 10.1186/s12888-016-1159-0.

12.

Peripheral Inflammatory Parameters in Late-Life Depression: A Systematic Review.

Martínez-Cengotitabengoa M, Carrascón L, O'Brien JT, Díaz-Gutiérrez MJ, Bermúdez-Ampudia C, Sanada K, Arrasate M, González-Pinto A.

Int J Mol Sci. 2016 Dec 2;17(12). pii: E2022. Review.

13.

Evidence of an epistatic effect between Dysbindin-1 and Neuritin-1 genes on the risk for schizophrenia spectrum disorders.

Prats C, Arias B, Moya-Higueras J, Pomarol-Clotet E, Parellada M, González-Pinto A, Peralta V, Ibáñez MI, Martín M, Fañanás L, Fatjó-Vilas M.

Eur Psychiatry. 2017 Feb;40:60-64. doi: 10.1016/j.eurpsy.2016.07.006. Epub 2016 Nov 14.

PMID:
27855309
14.

The Efficacy of Non-Pharmacological Interventions on Brain-Derived Neurotrophic Factor in Schizophrenia: A Systematic Review and Meta-Analysis.

Sanada K, Zorrilla I, Iwata Y, Bermúdez-Ampudia C, Graff-Guerrero A, Martínez-Cengotitabengoa M, González-Pinto A.

Int J Mol Sci. 2016 Oct 24;17(10). pii: E1766. Review.

15.

Psychometric properties and validation of a four-item version of the Strauss-Carpenter scale in bipolar disorder.

Alberich S, Barbeito S, González-Ortega I, Ugarte A, Vega P, de Azúa SR, López P, Zorrilla I, González-Pinto A.

Int J Bipolar Disord. 2016 Dec;4(1):22. Epub 2016 Oct 18.

16.

Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.

Mezquida G, Penadés R, Cabrera B, Savulich G, Lobo A, González-Pinto A, Penzol MJ, Corripio I, Fernandez-Egea E, Gassó P, Cuesta MJ, Bernardo M; PEPs group..

Eur Psychiatry. 2016 Oct;38:61-69. doi: 10.1016/j.eurpsy.2016.04.011. Epub 2016 Sep 24.

PMID:
27668551
17.

Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorder.

Pacchiarotti I, León-Caballero J, Murru A, Verdolini N, Furio MA, Pancheri C, Valentí M, Samalin L, Roigé ES, González-Pinto A, Montes JM, Benabarre A, Crespo JM, de Dios Perrino C, Goikolea JM, Gutiérrez-Rojas L, Carvalho AF, Vieta E.

Eur Neuropsychopharmacol. 2016 Oct;26(10):1562-78. doi: 10.1016/j.euroneuro.2016.08.008. Epub 2016 Aug 24. Review.

PMID:
27568278
18.

Online information seeking by patients with bipolar disorder: results from an international multisite survey.

Conell J, Bauer R, Glenn T, Alda M, Ardau R, Baune BT, Berk M, Bersudsky Y, Bilderbeck A, Bocchetta A, Bossini L, Paredes Castro AM, Cheung EY, Chillotti C, Choppin S, Del Zompo M, Dias R, Dodd S, Duffy A, Etain B, Fagiolini A, Garnham J, Geddes J, Gildebro J, Gonzalez-Pinto A, Goodwin GM, Grof P, Harima H, Hassel S, Henry C, Hidalgo-Mazzei D, Kapur V, Kunigiri G, Lafer B, Lam C, Larsen ER, Lewitzka U, Licht R, Lund AH, Misiak B, Piotrowski P, Monteith S, Munoz R, Nakanotani T, Nielsen RE, O'Donovan C, Okamura Y, Osher Y, Reif A, Ritter P, Rybakowski JK, Sagduyu K, Sawchuk B, Schwartz E, Scippa ÂM, Slaney C, Sulaiman AH, Suominen K, Suwalska A, Tam P, Tatebayashi Y, Tondo L, Vieta E, Vinberg M, Viswanath B, Volkert J, Zetin M, Zorrilla I, Whybrow PC, Bauer M.

Int J Bipolar Disord. 2016 Dec;4(1):17. doi: 10.1186/s40345-016-0058-0. Epub 2016 Aug 24. Erratum in: Int J Bipolar Disord. 2017 Dec;5(1):18.

19.

Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History.

González-Pinto A, González-Ortega I, Alberich S, Ruiz de Azúa S, Bernardo M, Bioque M, Cabrera B, Corripio I, Arango C, Lobo A, Sánchez-Torres AM, Cuesta MJ; PEPs Group..

PLoS One. 2016 Aug 11;11(8):e0160949. doi: 10.1371/journal.pone.0160949. eCollection 2016.

20.

Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial.

González-Ortega I, Echeburúa E, García-Alocén A, Vega P, González-Pinto A.

Trials. 2016 Jul 29;17:372. doi: 10.1186/s13063-016-1507-x.

Supplemental Content

Loading ...
Support Center